A recent study conducted by Brixner and colleagues found that payer experts agreed on several areas on preapproval information exchange (PIE) as it relates to health care economic information (HCEI).
The study’s results were published in the February edition of the Journal of Managed Care Pharmacy.
The five payer experts agree that PIE should encompass new molecular entities and indications of marketed therapies; that PIE assists with proactive budgeting, formulary decision-making and patient access; and that there exists a need for legislative safe harbor.
“The full contribution of PIE to improving the U.S. health system can best be realized under a safe harbor that allows U.S. PHDM [population health decision makers] and manufacturer experts to engage in robust scientific and economic discourse,” the authors state. “Additional research and broad stakeholder engagement is needed to advance the development of formal U.S. PIE guidelines.”
To read the study on JMCP, click here.